ARAP1 and type 2 diabetes mellitus: Overall, our data are in line with Kulzer and Strawbridge’s results, where higher levels of ARAP1 mRNA are associated with an increased risk of T2D and decreased proinsulin release, while the reduction in ARAP1 levels or function ameliorates β-cell function and T2D risk.